Skip to main content
Commentary

Sidelining safety — the FDA's inadequate response to the IOM.

Smith SW. Sidelining safety--the FDA's inadequate response to the IOM. N Engl J Med. 2007;357(10):960-3.

Save
Print
September 12, 2007
Smith SW. N Engl J Med. 2007;357(10):960-3.

In this perspective, the author discusses how the organizational culture of the US Food and Drug Administration (FDA) must change to foster a culture of safety.

Save
Print
Cite
Citation

Smith SW. Sidelining safety--the FDA's inadequate response to the IOM. N Engl J Med. 2007;357(10):960-3.